把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注，缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存；每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR，A 股链接巨潮原始 PDF，港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性，不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查；超出容差的记录保留原值并标记警告， 不会为了让公式“对上”而修改公司披露。
| 2026-03-31 |
| 3/3 |
| — |
| -$23.52M |
| -$21.19M |
| — |
| — |
| 27 |
| 尚无授权文本 |
| CLVT CLARIVATE PLC | 2026-03-31 | 3/3 | $585.5M | -$40.2M | $78.9M | 67.2% | 5.2% | 122 | 尚无授权文本 |
| IE Ivanhoe Electric Inc. | 2026-03-31 | 3/3 | $858,000 | $41.74M | -$42.91M | 58.9% | 11276.9% | 69 | 尚无授权文本 |
| INVA Innoviva, Inc. | 2026-03-31 | 3/3 | $97.99M | $186.6M | $34.79M | 77.4% | 38.9% | 81 | 尚无授权文本 |
| LIVN LivaNova PLC | 2026-03-31 | 3/3 | $362.26M | $22.29M | $926,000 | 67.3% | 11.4% | 96 | 尚无授权文本 |
| ROIV Roivant Sciences Ltd. | 2026-03-31 | 3/3 | $8.26M | -$299.77M | -$758.56M | — | -6235.7% | 93 | 尚无授权文本 |
| TOVX Theriva Biologics, Inc. | 2026-03-31 | 3/3 | $300,000 | -$2.04M | — | — | -709.0% | 150 | 尚无授权文本 |
| VANI Vivani Medical, Inc. | 2026-03-31 | 3/3 | — | -$6.78M | -$6.2M | — | — | 113 | 尚无授权文本 |
| VIVK Vivakor, Inc. | 2026-03-31 | 3/3 | $19.46M | -$4.58M | — | 29.4% | -12.5% | 123 | 尚无授权文本 |
| WK WORKIVA INC | 2026-03-31 | 3/3 | $247.31M | $19M | $25.75M | 80.4% | 6.2% | 75 | 尚无授权文本 |
| ABVX Abivax S.A. | 2025-12-31 | 2/3 | — | -$336.1M | — | — | — | 38 | 尚无授权文本 |
| TRVG trivago N.V. | 2025-12-31 | 3/3 | — | $11.22M | — | — | — | 57 | 尚无授权文本 |
| IVA Inventiva S.A. | 2025-06-30 | 2/3 | — | -$175.88M | — | — | — | 147 | 尚无授权文本 |
| BPRE Bluerock Private Real Estate Fund | — | 0/3 | — | — | — | — | — | 1 | 尚无授权文本 |
| BTX BlackRock Technology & Private Equity Term Trust | — | 0/3 | — | — | — | — | — | 0 | 尚无授权文本 |